Laurie Barclay, MD Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS/HIPEC) appears to be safe and effective for select patients with advanced abdominal cancers, according to a retrospective analysis published in the June issue of Cancer Medicine. “There has been much discussion as to whether there is a benefit with this procedure, and historically it has been associated with a lot of risk,” senior author Joseph J. Skitzki, MD, a surgical oncologist at Roswell Park Cancer Institute in Buffalo, New York, said in a news release. “However, reviewing our data in patients treated with CS/HIPEC over the last decade showed a...